CompoAtlas

Mélatonine 10 mg liberation lente

Natural health product licensed in Canada

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
N-[2-(5-méthoxy-1H-indol-3-yl)éthyl]acétamide

Source : Mélatonine

10 mgNot calculated

Non-medicinal ingredients

Hypromellose, Croscarmellose de sodium, Carmin d'indigo, Oxyde de fer jaune, Cellulose microcristalline, Phosphate de calcium, dibasique, Gel de silice colloïdal, Poly(éthylène glycol), Dioxyde de titane, Stéarate de magnésium, Poly(alcool vinylique)

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years1 Comprimé1 Tous les jours

Uses authorised in Canada

Aide à augmenter la durée totale du sommeil (aspect de la qualité du sommeil) chez les personnes souffrant de restriction du sommeil ou d'horaire altéré du sommeil (par ex., travail à horaire variable, décalage horaire). Aide à prévenir et/ou réduire les effets du décalage horaire/minimiser le décalage horaire (par ex., fatigue diurne, sommeil perturbé) (pour les personnes voyageant en avion vers l'est et traversant deux fuseaux horaires ou plus/si vous voyagez vers l'est sur deux fuseaux horaires ou plus). Aide à accélérer/réduire le temps nécessaire pour s'endormir (aspect délai d'endormissement de la qualité du sommeil) chez les personnes qui s'endorment lentement/souffrant du syndrome de retard de phase du sommeil. Aide à rétablir le cycle veille-sommeil (aspect du rythme circadien).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Product record

Licence holder
Laboratoire LSL Inc.
NPN or DIN-HM
80089079
Status
Active licence
Licence date
7 November 2018
Revision date
2 November 2023
Form
Comprimé, libération retardée
Route of administration
Orale
Application type
Non traditionnelle

Source

Official Health Canada record, licence 80089079

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Photograph the packaging

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Mélatonine 10 mg liberation lente (Laboratoire LSL Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80089079-melatonine-10-mg-liberation-lente, updated 2 November 2023.

List recorded in 2023. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line